Skip to main content
    D

    Definitive Healthcare Corp (DH)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $1.00
    +0.01 (+1.09%)

    Market Cap: $104.76M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    86%(18/21)
    Avg Surprise
    +39.95%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.04
    Range$0.04 - $0.05
    7 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$0.04-2.8%
    60d ago$0.04-3.2%
    30d ago$0.04-4.3%
    7d ago$0.040.0%
    Current$0.04
    Revenue Consensus
    $55M
    Range$54M - $55M
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.08
    Range$0.07 - $0.09
    7 analysts
    Revenue Consensus
    $56M
    Range$56M - $57M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.08---
    Sep 26EST
    		-$0.04---
    Jun 26
    Reported Aug 10
    		$0.01N/A-75.00%Miss-50.0%
    Mar 26
    Reported May 7
    		$0.06$0.03+100.00%Beat+20.0%
    Dec 25
    Reported Feb 26
    		$0.06$0.03+100.00%Beat-25.0%
    Sep 25
    Reported Nov 6
    		$0.07$0.06+16.67%Beat-30.0%
    Jun 25
    Reported Aug 7
    		$0.02$0.02+0.00%Beat-77.8%
    Mar 25
    Reported May 8
    		$0.05$0.02+150.00%Beat-37.5%
    Dec 24
    Reported Feb 27
    		$0.08$0.07+11.42%Beat+14.3%
    Sep 24
    Reported Nov 7
    		$0.10$0.08+25.00%Beat+11.1%
    Jun 24
    Reported Aug 5
    		$0.09$0.09+0.00%Beat+12.5%
    Mar 24
    Reported May 7
    		$0.08$0.08+0.00%Beat+33.3%
    Dec 23
    Reported Feb 28
    		$0.07$0.08-12.50%Miss+0.0%
    Sep 23
    Reported Nov 2
    		$0.09$0.06+50.00%Beat+50.0%
    Jun 23
    Reported Aug 14
    		$0.08$0.06+33.33%Beat+33.3%
    Mar 23
    Reported May 4
    		$0.06$0.04+50.00%Beat+20.0%
    Dec 22
    Reported Feb 23
    		$0.07$0.04+75.00%Beat+75.0%
    Sep 22
    Reported Nov 3
    		$0.06$0.05+20.00%Beat+500.0%
    Jun 22
    Reported Aug 4
    		$0.06$0.05+20.00%Beat+50.0%
    Mar 22
    Reported May 5
    		$0.05$0.04+25.00%Beat+151.3%
    Dec 21
    Reported Feb 23
    		$0.04$0.04+0.00%Beat+141.1%
    Sep 21
    Reported Nov 8
    		$0.01$0.02-50.00%Miss-
    Jun 21
    Reported Sep 16
    		$0.04$0.01+300.00%Beat-
    Mar 21
    Reported Jun 30
    		$-0.10$0.00N/AMiss-
    Dec 20
    Reported Mar 31
    		$-0.10$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio4.98EV/EBITDAN/A
    Price/FCF3.69xFCF Yield27.10%
    Profitability
    Profit Margin-72.30%Operating Margin-8.55%
    ROE-78.40%ROIC-75.14%
    Financial Health
    Debt/Equity1.11xInterest Coverage-20.92x
    Current Ratio1.86xQuick Ratio1.86x
    Trading Statistics
    Beta1.40Avg Volume714.00K
    52-Week High$3.0452-Week Low$0.61

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.98
    SMA 20$0.96
    SMA 50$0.88
    SMA 200$1.16
    EMA 10$0.98
    EMA 20$0.96
    EMA 50$0.92
    EMA 200$1.27

    MACD

    Line: 0.02Signal: 0.02Hist: -0.00

    ADX

    ADX: 28.4+DI: 25.5-DI: 15.1

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down32.0
    PSAR$0.92

    Bollinger Bands

    Upper Band$1.03
    Lower Band$0.88
    %B Position1531%(Upper)
    Band Width0.76

    RSI (14-Day)

    Neutral
    58.5

    Momentum Oscillators

    Stoch %K74.3
    Stoch %D66.6
    Williams %R-4.0
    ROC (10d)6.4%
    Momentum0.06
    CCI (20d)80.5
    MFI (14d)30.3

    Volatility Measures

    ATR (14d)$0.04(4.1%)
    StdDev (20d)0.04
    Hist Vol66.5%(High)

    Volume Flow

    VWAP$0.99
    OBV13.4M
    AD Line-21.0M
    CMF (20d)-0.494

    Volume Metrics

    Avg Vol (20d)736.7K
    Vol Ratio0.2x(Low)
    VWMA (20d)$0.93

    Pivot Points

    R3$1.02
    R2$1.01
    R1$1.00
    Pivot Point$0.99
    S1$0.98
    S2$0.97
    S3$0.96

    Advanced Oscillators

    TSI11.88
    Ultimate Osc40.2
    KST102.06

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$55.20M$55.93M$61.53M$60.05M$60.75M$59.19M$62.29M$62.70M$63.74M$63.48M$65.93M$65.33M
    Cost of Revenue$14.65M$14.28M$14.63M$14.05M$14.14M$15.43M$14.69M$13.67M$13.28M$13.10M$12.51M$11.89M
    Gross Profit$40.54M$41.65M$46.91M$45.99M$46.61M$43.76M$47.60M$49.03M$50.45M$50.38M$53.42M$53.43M
    Operating Expenses$47.29M$242.94M$73.54M$54.68M$50.78M$228.55M$147.16M$274.40M$420.10M$66.63M$63.50M$348.81M
    R&D$6.76M$6.50M$9.95M$7.55M$7.97M$9.30M$8.98M$7.28M$10.12M$10.13M$11.57M$10.76M
    SG&A$10.81M$12.08M$14.32M$12.36M$12.67M$12.27M$8.50M$11.35M$12.53M$16.88M$16.57M$14.54M
    Operating Income$-6,748,000$-201,290,000$-26,627,000$-8,688,000$-4,170,000$-184,786,000$-99,563,000$-225,367,000$-369,641,000$-16,249,000$-10,080,000$-295,378,000
    Interest Income$1.25M$1.30M$1.48M$1.67M$1.75M$2.05M$3.21M$3.74M$3.72M$3.93M$3.77M$3.46M
    Interest Expense$2.63M$2.63M$2.87M$3.00M$2.99M$2.94M$3.51M$3.75M$3.76M$3.82M$3.90M$3.90M
    Income Before Tax$-7,797,000$-195,789,000$-17,200,000$-17,268,000$-8,809,000$-165,979,000$-90,612,000$-201,548,000$-328,087,000$-13,498,000$-12,187,000$-266,222,000
    Income Tax Expense$-345,000$-3,435,000$-53,000$524,000$456,000$-10,886,000$-5,895,000$-13,724,000$-21,900,000$-780,000$1.18M$-17,534,000
    Net Income$-7,452,000$-192,354,000$-17,147,000$-17,792,000$-9,265,000$-155,093,000$-84,717,000$-187,824,000$-306,187,000$-12,718,000$-13,362,000$-248,688,000
    EBITDA$11.24M$-177,309,000$2.16M$2.25M$10.88M$-147,201,000$-73,024,000$-184,359,000$-311,250,000$2.94M$4.60M$-249,141,000
    EBIT$-6,422,000$-194,457,000$-15,816,000$-15,937,000$-7,568,000$-165,091,000$-90,309,000$-201,541,000$-328,041,000$-13,609,000$-12,062,000$-265,789,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about DH

    Government Contracts

    Gov Obligations (TTM)
    $35394
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    2
    New Awards (TTM)
    1
    Avg Remaining Term
    5.6 mo

    Top agency: Department of Health and Human Services at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75D30126P20910Department of Health and Human ServicesCenters for Disease Control and Prevention$35394Apr 30, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    CFO Casey Heller had 12,542 shares withheld for taxes at Definitive Healthcare (DH).

    Definitive Healthcare Corp.'s CFO, Casey Heller, had 12,542 shares of Class A Common Stock withheld on October 1, 2026...

    Stock Titan•10/6/26•Neutral

    Tax withholding leaves Definitive Healthcare (DH) legal chief with 864,534 shares.

    Definitive Healthcare's Chief Legal Officer, Jonathan Paris, had 7,729 shares of Class A Common Stock withheld by the issuer on October 1, 2026...

    Stock Titan•10/6/26•Neutral

    Definitive Healthcare CFO Casey Heller Withholds Shares for Tax on RSU Vesting

    Definitive Healthcare CFO Casey Heller withheld 12,542 shares of Class A Common Stock on October 1, 2026, to cover tax obligations arising from the vesting and settlement of previously granted Restricted Stock Units...

    Kalkine Media•10/5/26•Neutral

    Form 13D/A Definitive Healthcare Corp. For: 1 October By Investing.com

    This article from Investing.com reports on a Form 13D/A filing by Definitive Healthcare Corp. for October 1st. The brief entry provides the filing information without further details or analysis...

    Investing.com Nigeria•10/2/26•Neutral

    Form 13D/A Definitive Healthcare Corp. For: 1 October By Investing.com

    This article announces the filing of Form 13D/A by Definitive Healthcare Corp. for October 1st. It briefly mentions the company's stock performance and includes a link to view comments.

    Investing.com UK•10/1/26•Neutral

    DH Valuation and Fair Value

    P/E
    5.0x
    Forward P/E
    5.3x
    P/FCF
    3.7x
    P/B
    0.7x
    See GNG's fair value

    DH Profitability: Margins, ROIC and FCF

    Gross margin
    75.2%
    Operating margin
    -8.6%
    Net margin
    -72.3%
    ROIC
    -75.1%
    ROE
    -78.4%
    FCF margin
    12.3%
    FCF yield
    27.1%

    DH Competitors

    CompanyTicker
    Genelux Corporation Common StockGNLX
    Vivani Medical Inc.VANI
    Stereotaxis IncSTXS
    Armata Pharmaceuticals IncARMP
    enGene Holdings Inc. Common StockENGN
    PDS Biotechnology CorpPDSB
    LENZ Therapeutics IncLENZ
    Unicycive Therapeutics IncUNCY

    Sector: Healthcare

    DH Analyst Ratings

    Consensus
    Hold
    Analysts
    8
    Strong Buy
    0
    Buy
    1
    Hold
    5
    Sell
    0
    Strong Sell
    2

    DH Bull Case vs Bear Case

    Bull case

    • DH beat EPS estimates in 75.0% of its last 8 reported quarters.

    Bear case

    • DH has a -72.3% net profit margin.
    • DH's quarterly revenue changed -9.1% year over year.

    DH Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    41.0%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.04
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 2 down

    Frequently Asked Questions About DH

    Does DH pay dividends?

    Definitive Healthcare Corp (DH) does not currently pay a regular dividend.

    What is DH's P/E ratio?

    Definitive Healthcare Corp has a price-to-earnings (P/E) ratio of 4.98.

    What is DH's market cap?

    Definitive Healthcare Corp (DH) has a market capitalization of $104.76M with a current stock price of $1.00.

    Related stocks

    Sector: Healthcare

    All stocks starting with D

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In